Prostate Cancer SBRT Offers ‘Excellent’ Long-Term Oncologic Control
Stereotactic body radiation therapy for localized prostate cancer is associated with high 12-year rates of biochemical disease-free survival.
Stereotactic body radiation therapy for localized prostate cancer is associated with high 12-year rates of biochemical disease-free survival.
Fluciclovine PET/CT plus conventional imaging vs conventional imaging alone to guide radiation therapy for men with recurrent PCa following radical prostatectomy results in improved failure-free survival, according to the first randomized trial comparing the 2 approaches.
Black race is associated with improved oncologic outcomes among men undergoing radiation-based therapy for high-risk prostate cancer, new findings suggest.
Pretreatment counts of 5 CTCs per 7.5 mL of blood or higher correlated with shorter survival compared with lower counts among men with metastatic castration-resistant prostate cancer treated with radium-223, a study found.
Compared with patients who undergo surgery alone for abdominal or pelvic cancers, those who receive radiation and chemotherapy are at elevated risk for secondary sarcomas.
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
This study compared body composition, cardiometabolic risk factors, and PS in adult survivors of pediatric abdominal/pelvic tumors with the general US population.
A large cross-sectional cohort study investigated the relationship between hearing loss and measures of neurocognition in survivors of childhood cancers.
Radiation therapy for higher-risk prostate cancer can be delayed for up to 6 months following initiation of hormonal therapy without incurring a greater mortality risk, a finding that has implications for patient care during the COVID-19 pandemic.
Allowing an approximately 24-month recovery period after prostate surgery before giving radiation therapy may be optimal for preserving erectile function provided oncologic control is not compromised, according to investigators.